fda approval status of bpc-157 tb-500 cjc-1295 ipamorelin ghk-cu BPC-157 vs. TB-500, CJC is cjc-1295 ipamorelin fda-approved Order
Description
The primary concern raised by the Norwegian IRB was that this RCT was violating the principle of clinical equipoise
Plug in the defaults to see what each dose delivers: Skincare (2.5 mL water with GHK-Cu anchor) Payload: GHK-Cu 2 mg BPC-157 0.4 mg TB-4 0.4 mg KPV 0.4 mg
NOT approved by FDA for human use
Start at the lower end of the dosing range to assess individual response
